Definium Therapeutics Inc. Common Shares vs Keurig Dr Pepper Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.68 (market cap $4.59B), while Keurig Dr Pepper Inc. Common Stock trades at $31.11 (market cap $42.54B). The key difference: Keurig Dr Pepper Inc. Common Stock is far larger — about 9.3× Definium Therapeutics Inc. Common Shares's market cap, and Keurig Dr Pepper Inc. Common Stock pays a 2.94% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Keurig Dr Pepper Inc. Common Stock for 0 Days on average.
| DFTX | KDP | |
|---|---|---|
Market Cap | $4.59B | $42.54B |
Volume | 2,103,937 | 14,530,234 |
Sector | Health | Consumer Staples |
52-Week High | $48.45 | $33.50 |
52-Week Low | $10.68 | $25.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $71.00B |
Dividend Yield | — | 2.94% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Keurig Dr Pepper produces and distributes coffee, soft drinks, juices, and other beverages. It also operates the Keurig single-serve coffee system.
Read more on KDP →